Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Sophonix (Beijing Meilian Tyco Biotech) closed a $14...
Deals and Financings
• VistaGen out-licensed...
MicuRx Pharma, a San Francisco-Shanghai biotech...
These presentations, white papers and other content are...
Investment Continues in Chinese Biotech In China,...
The ChinaBio® Investor Forum took place in Shanghai...
Reflecting the worldwide stock market slide, the...
We have just concluded our 4th ChinaBio® Investor...
Sundia MediTech Company, a Shanghai CRO, was named a Top...
OriGene Technologies, Inc., a gene-centric life sciences...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
